Project Grant R35GM165963
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $377K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Fort Collins, CO 80521, USA
Similar Awards
- The National Institute of General Medical Sciences awarded The Regents of the University of Colorado $386,994 on August 5, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to identify ecological forces driving global divergence in infant microbiome assembly. The recipient will conduct multi-omics profiling of global infant cohorts to identify correlations between microbiome composition and ecological pressures including human milk oligosaccharides (HMOs) and...
- The National Science Foundation awarded Colorado State University a $1,167,241 project grant under the Biological Sciences federal grant program (CFDA 47.074) to support the acquisition of an ultrahigh resolution mass spectrometry system. The system will enable metaproteomics experiments to advance microbiome research. The three-year award period runs from October 1, 2021 through September 30, 2024. As the prime awardee, Colorado State University will utilize the funding to procure an advanced...
- This National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) Project Grant award of $900,000.00 to Colorado State University (CSU) aims to develop a novel microbiome modeling platform. The platform will integrate omics data, thermodynamics principles, metabolic models, and artificial intelligence to unravel the metabolism, interactions, and evolution of microbiomes. This research will be applied to address specific questions regarding the microbiome of a "rewired...
- The National Institute of Allergy and Infectious Diseases awarded Colorado State University $423,500 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate bacteriophage interactions with nontuberculous mycobacteria in mammalian cell intracellular environments. The research addresses the therapeutic use of bacteriophages—naturally occurring viruses that infect and kill bacteria—as an alternative treatment for drug-resistant nontuberculous...
- The National Institute of General Medical Sciences awarded Trustees of Boston University $449,625 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods for discovering temporal changes in host-microbiome interactions. The award funds development of a deep learning framework led by principal investigator Dr. Chao Zhang. The project will deliver two primary outputs over five years: a microorganism identification pipeline using...
- The National Institute of General Medical Sciences awarded the University of Wisconsin System $418,331 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) for advanced statistical methods for microbiome data analysis. The award funds development of innovative batch-effect correction methods, meta-analysis techniques, and robust causal-inference tools to address methodological gaps in microbiome research. The recipient will develop and disseminate...
- The National Science Foundation Division of Biological Infrastructure awarded The Regents of the University of Colorado (doing business as University of Colorado-Denver) $1,000,001 on September 1, 2026, under the Biological Sciences program (CFDA 47.074) to develop artificial intelligence and machine learning methods that detect genomic patterns linked to microbial niche adaptation across bacterial lineages including Staphylococcus, Pseudomonas, and Mycobacterium. The work addresses the...
- The National Institute of General Medical Sciences awarded the University of Chicago $451,000 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct systematic interrogation of diet as a mechanism to shape microbial community configuration and metabolism. The research examines how dietary macronutrients drive growth of specific microbial clades within a complex but defined human microbiome (HCOM2), utilizing in vitro analysis across a panel of...
- The National Institute of General Medical Sciences awarded Arizona State University $300,000 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate synthetic microbial communities and their ecosystem dynamics. The project develops and characterizes synthetic two-component and higher-order E. coli microbial communities with diverse inter-strain interaction topologies, coupling bacterial toxin-antitoxin systems with quorum sensing to create...
- The National Institute of General Medical Sciences awarded the Regents of the University of Colorado–Denver $162,501 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop cross-disciplinary training in high-dimensional data analysis and communication for the next generation of biostatisticians and epidemiologists. The award funds a training program that equips trainees with analytical methods for handling complex biomarker data—including...